A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.

NCT00283218 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: NovoRapid, NovoMix 30, Bifasisk Insulin Aspart 50, BIAsp70

Sponsor

University of Aarhus

Collaborators

[object Object]